Stigmasterol Inhibits Breast Cancer Stemness and Tumor Growth by Suppressing TGF-β/SMAD Signaling Pathway
Breast Cancer: Targets and Therapy · 2026-11 · Volume 18 · 1-17
DOI: 10.2147/bctt.s642032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer: Targets and Therapy, 2026-11. Verfasst von Yuzhu Zhang und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhang, Y., Zheng, C., He, B., Li, Y., Lin, X., Song, H., Wu, R., & Hong, R. (2026). Stigmasterol Inhibits Breast Cancer Stemness and Tumor Growth by Suppressing TGF-β/SMAD Signaling Pathway. Breast Cancer: Targets and Therapy, Volume 18, 1-17. https://doi.org/10.2147/bctt.s642032
Vancouver
Zhang Y, Zheng C, He B, Li Y, Lin X, Song H, et al. Stigmasterol Inhibits Breast Cancer Stemness and Tumor Growth by Suppressing TGF-β/SMAD Signaling Pathway. Breast Cancer: Targets and Therapy. 2026;Volume 18:1-17. doi:10.2147/bctt.s642032
BibTeX
@article{Zhang2026,
author = {Zhang, Yuzhu and Zheng, Chenhui and He, Binjun and Li, Ying and Lin, Xiaoru and Song, Hongming and Wu, Ruixian and Hong, Ri},
title = {Stigmasterol Inhibits Breast Cancer Stemness and Tumor Growth by Suppressing TGF-β/SMAD Signaling Pathway},
journal = {Breast Cancer: Targets and Therapy},
year = {2026},
volume = {Volume 18},
pages = {1--17},
doi = {10.2147/bctt.s642032}
}
EUVIMED